Kosteneffectiviteit bepalen bij behandeling met mini-hart/longmachine bij kritisch zieke patiënten

Cost-effectiveness of Extracorporeal Life Support (ECLS) Treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON25049

Enrollment

210

Registered

2017-07-27

Start date

2017-12-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure, respiratory failure, extracorporeal life support, extracorporeal membrane oxygenation, intensive care, hartfalen, longfalen

Interventions

ECLS as considered appropriate

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive adult patients who receive ECLS in one of the participating centers

Exclusion criteria

Exclusion criteria: < 18 years not able to give informed consent

Design outcomes

Primary

Measure	Time frame
Health related quality of life assessed with EQ-5D-5L questionnaire 12 months after initiation of ECLS treatment	—

Secondary

Measure	Time frame
Secondary outcome is survival. Additional measurements are EQ-5D-VAS score and societal costs.	—

Contacts

Public ContactA. Oude Lansink

afdeling Intensive Care Volwassenen

a.oudelansink@umcg.nl050-3616161

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)